Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Coyle

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
JAMA Psychiatry|May 24, 2013
Nitric oxide and symptom reduction in schizophreniaJoseph T Coyle
Archives of General Psychiatry|June 12, 2013
Changing to JAMA PsychiatryJoseph T Coyle
Advances in Experimental Medicine and Biology|June 29, 2006
A brief overview of N-acetylaspartate and N-acetylaspartylglutamateJoseph T Coyle
The American Journal of Psychiatry|June 2, 2017
Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic SchizophreniaJoseph T Coyle
Neurotoxicity Research|January 2, 2007
Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanismsJoseph T Coyle
Biochemical Pharmacology|June 21, 2024
Passing the torch: The ascendance of the glutamatergic synapse in the pathophysiology of schizophreniaJoseph T Coyle
Archives of General Psychiatry|November 16, 2017
Reviewers Who Completed a Review During 2011Joseph T Coyle
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2009
MicroRNAs suggest a new mechanism for altered brain gene expression in schizophreniaJoseph T Coyle
Experimental Neurology|November 23, 2005
Glial metabolites of tryptophan and excitotoxicity: coming ungluedJoseph T Coyle
Biochemical Pharmacology|September 29, 2004
The GABA-glutamate connection in schizophrenia: which is the proximate cause?Joseph T Coyle
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
JAMA Psychiatry|May 24, 2013
Nitric oxide and symptom reduction in schizophreniaJoseph T Coyle
Archives of General Psychiatry|June 12, 2013
Changing to JAMA PsychiatryJoseph T Coyle
Advances in Experimental Medicine and Biology|June 29, 2006
A brief overview of N-acetylaspartate and N-acetylaspartylglutamateJoseph T Coyle
The American Journal of Psychiatry|June 2, 2017
Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic SchizophreniaJoseph T Coyle
Neurotoxicity Research|January 2, 2007
Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanismsJoseph T Coyle
Biochemical Pharmacology|June 21, 2024
Passing the torch: The ascendance of the glutamatergic synapse in the pathophysiology of schizophreniaJoseph T Coyle
Archives of General Psychiatry|November 16, 2017
Reviewers Who Completed a Review During 2011Joseph T Coyle
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2009
MicroRNAs suggest a new mechanism for altered brain gene expression in schizophreniaJoseph T Coyle
Experimental Neurology|November 23, 2005
Glial metabolites of tryptophan and excitotoxicity: coming ungluedJoseph T Coyle
Biochemical Pharmacology|September 29, 2004
The GABA-glutamate connection in schizophrenia: which is the proximate cause?Joseph T Coyle
Pageof 14